BSE filing, NSE: KERALAYUR. Summary written from the filing by ALFA Finder's alert engine.
Kerala Ayurveda Ltd: key numbers
- Share price
- ₹138.95
- Market cap
- ₹167.2 Cr
- Revenue (annual)
- ₹131.2 Cr
- Net profit (annual)
- ₹-16.32 Cr
- P/E (TTM)
- -6.3×Sector 48.6×
- Promoter holding
- 38.70%+3.09% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kerala Ayurveda Ltd
All →Kerala Ayurveda Results Update
Kerala Ayurveda reported H1 FY27 revenue from operations of Rs.68.9 Crs, up 8.7%, with Q2 EBITDA losses narrowing. The press release reiterates targets for monthly operating EBITDA breakeven in H2 FY27 and a potential fund raise.
Kerala Ayurveda Q2 FY27 Results: Net Loss of ₹6.1 Cr, Loss Narrows
Kerala Ayurveda Ltd reported revenue from operations of ₹35.7 Cr (+2.6% YoY) and a net loss of ₹6.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹6.1 Cr
Kerala Ayurveda Board Meeting Date
Kerala Ayurveda has given prior intimation of a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-year results for September 2026. Trading window closes from 30 September 2026 until 48 hours after results are declared.
Kerala Ayurveda Capital Structure Change
Kerala Ayurveda's board approved allotment of 6,55,000 equity shares at Rs.190.37 to promoter-group entity Katra Holding, settled by adjusting an unsecured loan. This is a capital structure change, with corporate action still pending.
- Value
- ₹124.7 Cr
Kerala Ayurveda Preferential Issue
Kerala Ayurveda allotted 6,55,000 preferential shares to Katra Holding at Rs. 190.37 each, totaling Rs. 12.47 Crore. The existing unsecured loan was adjusted as consideration.
- Value
- ₹12.47 Cr
Kerala Ayurveda Other Announcement
Kerala Ayurveda Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026, as required by SEBI regulations.
Other acquisition announcements
All →Jio Financial Services Acquisition Worth ₹123 Cr
Jio Financial invested Rs 123 crore in its 50:50 JV with BlackRock via a rights issue. The arm's-length related-party deal needs no regulatory approval.
- Value
- ₹123.0 Cr
Lords Chloro Alkali Acquisition Worth ₹3.09 Cr
Lords Chloro Alkali will invest Rs.3.09 Crore for a 2.56% stake in CGE II Hybrid Energy, securing extra hybrid power. Closing targeted by November 30.
- Value
- ₹3.09 Cr
Cyber Media Research & Services Acquisition Worth ₹0.2 Cr
Cyber Media converted CCDs into 2,000 APL shares at Rs.1,000 each, lifting its stake to 23.80%. APL becomes an associate, with related-party terms at arm's length.
- Value
- ₹0.20 Cr
3B BlackBio Dx Acquisition Worth ₹2.8 Cr
Coris, 3B's Belgian subsidiary, will acquire 100% of Bilex SRL for ₹2.80 Crore. The deal ends rent payments, saving about €140,000 yearly.
- Value
- ₹2.80 Cr
LT Foods Acquisition Worth ₹53.94 Cr
LT Foods' US subsidiary will buy 100% of MK Foods, owner of Maya Kaimal, for USD 5.8 million. Completion is expected within three months, paid in cash.
- Value
- ₹53.94 Cr
- Execution
- Within 3 months
Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.